ReviewReviews in endocrine & metabolic disorders2020

Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.

Han Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.